Horst & Graben Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264K Buy
732
+6
+0.8% +$2.05K 0.03% 177
2026
Q1
$247K Buy
726
+13
+2% +$4.63K 0.03% 177
2025
Q4
$233K Buy
+713
New +$226K 0.04% 163
2025
Q2
Sell
-703
Closed -$219K 174
2025
Q1
$219K Buy
+703
New +$208K 0.04% 153
2024
Q4
Sell
-683
Closed -$220K 157
2024
Q3
$220K Sell
683
-128
-16% -$41.9K 0.04% 147
2024
Q2
$253K Sell
811
-14
-2% -$4.11K 0.05% 124
2024
Q1
$235K Buy
825
+5
+0.6% +$1.46K 0.05% 129
2023
Q4
$236K Buy
820
+22
+3% +$5.99K 0.05% 120
2023
Q3
$215K Buy
+798
New +$199K 0.05% 123
2023
Q1
Sell
-772
Closed -$203K 132
2022
Q4
$203K Buy
+772
New +$207K 0.05% 124

Other funds holding AMGN

Horst & Graben Wealth Management's AMGN Position: Q2 2026 in Review

Horst & Graben Wealth Management increased its Amgen (AMGN) stake by 0.83% in Q2 2026, buying an estimated $2.05K and bringing the position to 732 shares worth $264K. The position accounts for 0.03% of the portfolio, ranked #177.

Horst & Graben Wealth Management first reported a position in AMGN in Q4 2022 and has held it in 10 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Horst & Graben Wealth Management held 732 shares of Amgen worth $264K as of Q2 2026.
  • Horst & Graben Wealth Management bought 6 Amgen shares in Q2 2026, an estimated $2.05K.
  • Amgen made up 0.03% of Horst & Graben Wealth Management's portfolio in Q2 2026, its #177 holding.
  • Horst & Graben Wealth Management first reported a position in Amgen in Q4 2022 and has held it in 10 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Horst & Graben Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.